RFPi and its proprietary medical imaging technology were featured at Biotech Showcase™ 2018 taking place Jan. 8-11 at the Hilton San Francisco Union Square.
Jeffery Basham, CEO, shared information about RFPi’s iCertainty™ platform —innovative medical imaging technology that provides immediate visualization and quantification of blood flow and perfusion without the need for injections, dyes, radiation or direct patient contact.
RFPi’s patent-protected and copyrighted iCertainty™ platform shows in real time where and how well blood flows in vascular structures and critical tissues during surgery.
Other existing imaging modalities — such as X-ray, ultrasound, CT scan, MRI or PET scan — can’t provide real-time images and data about blood flow and perfusion without significantly interrupting the surgical procedure, requiring patient contact or increasing patient risk.
RFPi’s working prototypes have been successfully deployed in three-plus years of pre-clinical and clinical studies. RFPi has submitted a 510(k) application with the U.S. Food and Drug Administration.
With patents covering 66 claims providing comprehensive intellectual property protection, RFPi anticipates commercializing proprietary blood-flow imaging devices that could:
- Improve clinical outcomes for patients, lessening discomfort and stress.
- Benefit surgeons by integrating views of physiologic circumstances during procedures in real time, without disrupting procedures or requiring patient contact.
- Mitigate costs for hospitals by reducing readmission rates for post-surgical complications, and
- Objectively measure outcomes, providing third-party payers with quantifiable performance data.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
RFPi’s technology was invented in 2010 at East Carolina University by a team of cardiovascular medicine, optical physics and engineering experts. Development has included bench-top and experimental studies, and clinical proof-of-concept and validation studies. This team continues to work closely with RFPi to commercialize these paradigm-changing medical imaging applications and devices.
Videos demonstrating how RFPi’s iCertainty™ platform works can be seen on the company’s website at www.rfpi-co.com.